Indeed, a few HLA class I alleles, mainly B*07, B*18, and B*40, exhibited a surprisingly reduced incidence in the NPM1-mutated patient group compared to controls, namely healthy subjects, and NPM1-wild-type AML patients. This evidence concerns the gene NPM1 and acute myeloid leukemia.